v3.26.3
Condensed Consolidated Statements of Stockholders’ Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2024   126,106,176      
Beginning balance at Dec. 31, 2024 $ 208,730 $ 13 $ 481,679 $ 57 $ (273,019)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   60,433      
Issuance of common stock upon exercise of vested stock options 26   26    
Issuance of common stock under employee stock purchase plan (in shares)   138,513      
Issuance of common stock under employee stock purchase plan 87   87    
Stock-based compensation expense 5,373   5,373    
Other comprehensive (loss) income 143     143  
Net loss (45,220)       (45,220)
Ending balance (in shares) at Sep. 30, 2025   126,305,122      
Ending balance at Sep. 30, 2025 169,139 $ 13 487,165 200 (318,239)
Beginning balance (in shares) at Jun. 30, 2025   126,305,122      
Beginning balance at Jun. 30, 2025 181,094 $ 13 485,669 77 (304,665)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation expense 1,496   1,496    
Other comprehensive (loss) income 123     123  
Net loss (13,574)       (13,574)
Ending balance (in shares) at Sep. 30, 2025   126,305,122      
Ending balance at Sep. 30, 2025 $ 169,139 $ 13 487,165 200 (318,239)
Beginning balance (in shares) at Dec. 31, 2025 126,469,610 126,469,610      
Beginning balance at Dec. 31, 2025 $ 156,973 $ 13 488,737 243 (332,020)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares) 774,221 774,221      
Issuance of common stock upon exercise of vested stock options $ 1,233   1,233    
Issuance of common stock under employee stock purchase plan (in shares)   84,786      
Issuance of common stock under employee stock purchase plan 142   142    
Stock-based compensation expense 3,828   3,828    
Other comprehensive (loss) income (815)     (815)  
Net loss $ (44,802)       (44,802)
Ending balance (in shares) at Sep. 30, 2026 127,328,617 127,328,617      
Ending balance at Sep. 30, 2026 $ 116,559 $ 13 493,940 (572) (376,822)
Beginning balance (in shares) at Jun. 30, 2026   127,224,640      
Beginning balance at Jun. 30, 2026 131,112 $ 13 492,616 (331) (361,186)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon exercise of vested stock options (in shares)   103,977      
Issuance of common stock upon exercise of vested stock options 26   26    
Stock-based compensation expense 1,298   1,298    
Other comprehensive (loss) income (241)     (241)  
Net loss $ (15,636)       (15,636)
Ending balance (in shares) at Sep. 30, 2026 127,328,617 127,328,617      
Ending balance at Sep. 30, 2026 $ 116,559 $ 13 $ 493,940 $ (572) $ (376,822)